Management of buprenorphine/naloxone therapy in substances abuse consumers in prison: efficacy and safety
The use of agonist therapy in prison is not widespread in Italy or in the rest of the world. This causes a strong limitation in access to care for inmates, but above all causes serious negative consequences on public health, due to the lack of treatment of a population otherwise difficult to reach....
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AboutScience Srl
2018-11-01
|
| Series: | AboutOpen |
| Subjects: | |
| Online Access: | https://journals.aboutscience.eu/index.php/aboutopen/article/view/52 |